Sign inGet started

Dentzer James E

Insider CIK 1400977 · CRIS President & CEO, Director · DRNA Chief Financial Officer · IMNN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IMNN Imunon, Inc. A Award2026-07-312026-08-046,934$1.59 $11.0K21,897SEC↗
IMNN Imunon, Inc. A Award2026-07-312026-08-046,934$1.59 $11.0K21,897SEC↗
CRIS CURIS INC A Award deriv2026-07-072026-07-09110,090$5.29 $582.4K110,090SEC↗
IMNN Imunon, Inc. A Award2026-05-222026-05-2711,148$2.20 $24.5K14,963SEC↗
CRIS CURIS INC C Conversion deriv2026-03-202026-03-23100— $00SEC↗
CRIS CURIS INC C Conversion2026-03-202026-03-23133,333— $0148,730SEC↗
CRIS CURIS INC A Award deriv2026-03-172026-03-18133,333— $0133,333SEC↗
CRIS CURIS INC A Award deriv2026-03-172026-03-18133,333— $0133,333SEC↗
CRIS CURIS INC A Award deriv2026-03-172026-03-18133,333— $0133,333SEC↗
CRIS CURIS INC A Award deriv2026-03-172026-03-18100— $0100SEC↗
IMNN Imunon, Inc. A Award deriv2026-01-022026-01-064,405— $04,405SEC↗
IMNN Imunon, Inc. A Award deriv2025-08-042025-08-06250— $0250SEC↗
IMNN Imunon, Inc. A Award2025-08-042025-08-063,318$9.20 $30.5K3,318SEC↗
CRIS CURIS INC A Award deriv2025-05-202025-05-22360,000$3.13 $1.13M360,000SEC↗
IMNN Imunon, Inc. A Award deriv2025-03-142025-03-183,750— $03,750SEC↗
CRIS CURIS INC A Award deriv2025-01-282025-01-3040,000$3.13 $125.2K40,000SEC↗
IMNN Imunon, Inc. A Award deriv2024-09-062024-09-103,634— $017,301SEC↗
IMNN Imunon, Inc. A Award deriv2024-06-122024-06-144,500— $013,667SEC↗
CRIS CURIS INC A Award deriv2024-05-212024-05-23100,000$11.62 $1.16M100,000SEC↗
IMNN Imunon, Inc. A Award deriv2024-03-152024-03-184,500— $09,167SEC↗
IMNN Imunon, Inc. A Award deriv2023-03-172023-03-212,000— $04,667SEC↗
CRIS CURIS INC A Award deriv2023-01-202023-01-241,000,000— $01,000,000SEC↗
IMNN Imunon, Inc. A Award deriv2022-09-302022-10-032,667— $02,667SEC↗
CRIS CURIS INC S Sale2022-01-312022-01-313,094$3.07 $9.5K64,877SEC↗
CRIS CURIS INC A Award deriv2022-01-292022-01-31825,000— $0825,000SEC↗
CRIS CURIS INC S Sale2022-01-272022-01-312,406$3.18 $7.7K67,971SEC↗
CRIS CURIS INC A Award deriv2021-01-282021-01-29330,000— $0330,000SEC↗
CRIS CURIS INC S Sale2021-01-262021-01-263,094$10.59 $32.8K67,268SEC↗
CRIS CURIS INC S Sale2021-01-252021-01-262,283$10.96 $25.0K70,362SEC↗
CRIS CURIS INC A Award deriv2020-03-022020-03-04750,000— $0750,000SEC↗
CRIS CURIS INC S Sale2020-01-242020-01-243,094$1.64 $5.1K42,158SEC↗
CRIS CURIS INC S Sale2020-01-232020-01-243,658$1.69 $6.2K45,252SEC↗
CRIS CURIS INC A Award deriv2019-05-232019-05-281,115,871— $01,115,871SEC↗
CRIS CURIS INC S Sale2019-01-242019-01-253,094$1.16 $3.6K41,639SEC↗
CRIS CURIS INC S Sale2019-01-232019-01-252,397$1.09 $2.6K44,733SEC↗
CRIS CURIS INC A Award deriv2018-09-262018-09-27750,000— $0750,000SEC↗
CRIS CURIS INC A Award deriv2018-05-152018-05-17825,000— $0825,000SEC↗
CRIS CURIS INC A Award2018-01-222018-01-24206,250— $0212,011SEC↗
CRIS CURIS INC A Award deriv2016-03-292016-03-301,700,000— $01,700,000SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2015-01-092015-01-1375,000— $075,000SEC↗
DRNA Dicerna Pharmaceuticals In A Award deriv2014-04-162014-04-18108,750— $0108,750SEC↗
CRIS CURIS INC A Award deriv2014-02-142017-02-16650,000— $0650,000SEC↗